| Super Retail Group Limited (SUL) ORDINARY FULLY PAID |
Consumer Discretionary |
$3,130 |
2024 AGM Addresses and Presentation
|
24 Oct 2024 8:37AM |
$16.750 |
$13.860 |
fallen by
17.25%
|
|
SUL - Price-sensitive ASX Announcement
Full Release
Key Points
- Record total Group revenue of $3.9 billion, up 2%
- Active club membership grew to 11.5 million, a 12% increase from the previous year
- 77% of total sales came from loyalty program members
- Resilient performance amid a challenging cost-of-living environment
- Plans to open 25 new stores in FY25, continuing expansion efforts
- Group maintains a strong cash position of $218 million with no drawn bank debt
- Recognition for gender pay equity and commitment to sustainability initiatives
- Focus on enhancing digital capabilities and customer personalization strategies
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Reliance Worldwide Corporation Limited (RWC) ORDINARY FULLY PAID |
Industrials |
$3,272 |
Chair's and CEO's addresses to Annual General Meeting
|
24 Oct 2024 8:37AM |
$5.710 |
$4.230 |
fallen by
25.92%
|
|
| HealthCo Healthcare and Wellness REIT (HCW) ORDINARY UNITS FULLY PAID |
Real Estate |
$415 |
Update - Notification of buy-back - HCW
|
24 Oct 2024 8:36AM |
$1.160 |
$0.755 |
fallen by
34.91%
|
|
| Fenix Resources Ltd (FEX) ORDINARY FULLY PAID |
Materials |
$208 |
Quarterly Activities Report
|
24 Oct 2024 8:36AM |
$0.260 |
$0.280 |
risen by
7.69%
|
|
FEX - Price-sensitive ASX Announcement
Full Release
Key Points
- Total export volume of 769,831 wet metric tonnes.
- Iron Ridge C1 cash costs reduced to A$78.8/wmt.
- Iron Ridge C1 operating margin of A$46/dmt.
- Production and haulage commenced at Shine Iron Ore Mine.
- Beebyn-W11 Iron Ore Mine development progress on track.
- Cash as at 30 September 2024 of A$72.0 million.
- Zero Lost Time Injuries reported.
- Fenix shipped its 5 millionth tonne from Iron Ridge.
- Ruvidini Inland Port terminal substantially completed.
- Investor webinar scheduled for 24 October 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$83 |
Wilsons Drug and Device Conference Presentation
|
24 Oct 2024 8:36AM |
$0.520 |
$0.345 |
fallen by
33.65%
|
|
| TasFoods Limited (TFL) ORDINARY FULLY PAID |
Consumer Staple |
$2 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
24 Oct 2024 8:34AM |
$0.012 |
$0.004 |
fallen by
66.67%
|
|
TFL - Price-sensitive ASX Announcement
Full Release
Key Points
- Gross margin from continued operations remained flat on prior comparable period.
- Operating Cash Flows improved significantly to $21.0k, up $0.5m from the prior period.
- TasFoods continues to progress the Pyengana Dairy growth strategy, including export accreditation.
- Isle & Sky pet treats expanded distribution through Petbarn and local grocers.
- Indirect costs reduced by 12.6% compared to the prior period.
- Total revenue for the Poultry division decreased by 7% compared to the prior comparable period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$9,750 |
Dividend/Distribution - NEM
|
24 Oct 2024 8:34AM |
$87.350 |
$89.300 |
risen by
2.23%
|
|
NEM - Price-sensitive ASX Announcement
Full Release
Key Points
- Newmont Corporation announced a dividend distribution of USD 0.25 per share.
- The ex-dividend date is November 26, 2024.
- The record date for the dividend is November 27, 2024.
- Payments will be made on December 23, 2024.
- CDI holders can elect to receive payment in different currencies.
- A 30% withholding tax applies to the dividend unless a lower rate is qualified under tax treaties.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$2,341 |
Insignia Financial 1Q25 Quarterly Business Update
|
24 Oct 2024 8:34AM |
$3.080 |
$3.490 |
risen by
13.31%
|
|
IFL - Price-sensitive ASX Announcement
Full Release
Key Points
- FUMA increased by $8.3 billion to $319.6 billion as of 30 September 2024.
- Total net outflows for the quarter were $1.0 billion.
- MLC Expand saw $522 million in underlying net inflows for the quarter.
- Separation from NAB is on track for 1H25.
- Master Trust FUA reached $130.8 billion, up $3.3 billion.
- Wrap FUA was $97.9 billion, an increase of $3.5 billion.
- Asset Management FUM increased by $1.5 billion to $90.8 billion.
- Expand's managed accounts capability hit $10 billion during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dexus (DXS) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$7,507 |
Annual General Meeting Resolution withdrawal
|
24 Oct 2024 8:32AM |
$7.280 |
$6.980 |
fallen by
4.12%
|
|
| Coppermoly Limited (COY) ORDINARY FULLY PAID |
Materials |
$12 |
Notice of Annual General Meeting
|
24 Oct 2024 8:32AM |
$0.010 |
$0.014 |
risen by
40%
|
|
| Audeara Limited (AUA) ORDINARY FULLY PAID |
Consumer Discretionary |
$4 |
Letter to Shareholders & Notice of AGM & Proxy Form
|
24 Oct 2024 8:31AM |
$0.042 |
$0.023 |
fallen by
45.24%
|
|
| Winton Land Limited (WTN) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Real Estate |
$555 |
Chair's Address to Shareholders
|
24 Oct 2024 8:30AM |
$1.600 |
$1.870 |
risen by
16.88%
|
|
| 3D Energi Limited (TDO) ORDINARY FULLY PAID |
Energy |
$42 |
2024 Annual General Meeting Presentation
|
24 Oct 2024 8:29AM |
$0.070 |
$0.125 |
risen by
78.57%
|
|
| Kelsian Group Limited (KLS) ORDINARY FULLY PAID |
Industrials |
$1,007 |
Kelsian Renews Jersey Channel Islands Contract
|
24 Oct 2024 8:28AM |
$4.120 |
$3.710 |
fallen by
9.95%
|
|
KLS - Price-sensitive ASX Announcement
Full Release
Key Points
- Kelsian named as Preferred Bidder for Jersey bus services contract.
- Contract is for a 10-year term starting April 2025.
- Estimated revenue of A$260 million over the contract term.
- LibertyBus will operate approximately 80 buses with 175 employees.
- Commitment to replace existing buses and grow electric fleet.
- Majority of the fleet expected to be battery electric by 2035.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$9,217 |
Update - Notification of buy-back - AFI
|
24 Oct 2024 8:27AM |
$7.430 |
$7.350 |
fallen by
1.08%
|
|
| 4DS Memory Limited (4DS) ORDINARY FULLY PAID |
Information Technology |
$54 |
4DS Memory presenting at Semiconductor Australia 2024
|
24 Oct 2024 8:27AM |
$0.095 |
$0.026 |
fallen by
72.63%
|
|
| Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$9,750 |
Third Quarter 2024 Results Release (Form 8-K)
|
24 Oct 2024 8:27AM |
$87.350 |
$89.300 |
risen by
2.23%
|
|
NEM - Price-sensitive ASX Announcement
Full Release
Key Points
- Newmont filed its Third Quarter 2024 Results Release as a Form 8-K.
- The filing was made with the SEC after market close on 23 October 2024.
- A conference call is scheduled for 24 October 2024 to discuss the results.
- The report can be accessed on Newmont’s website and the SEC EDGAR site.
- Newmont is recognized for its principled environmental, social, and governance practices.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$52 |
Quarterly Activities Report and Appendix 4C
|
24 Oct 2024 8:26AM |
$0.140 |
$0.245 |
risen by
75%
|
|
NYR - Price-sensitive ASX Announcement
Full Release
Key Points
- Nyrada successfully completes Good Laboratory Practice safety studies of lead drug candidate NYR-BI03.
- Preclinical efficacy study showed NYR-BI03 provided an 86% cardioprotective effect following myocardial ischemic-reperfusion injury.
- Australian based Contract Research Organisation engaged to conduct first-in-human Phase I clinical trial for NYR-BI03 commencing in late 2024.
- Cash position of AU$2.98 million as at 30 September 2024.
- AU$1.38 million R&D tax rebate expected in late 2QFY2025.
- The company submitted patent applications to protect its TRPC channel intellectual property assets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Super Retail Group Limited (SUL) ORDINARY FULLY PAID |
Consumer Discretionary |
$3,130 |
Trading Update
|
24 Oct 2024 8:26AM |
$16.750 |
$13.860 |
fallen by
17.25%
|
|
SUL - Price-sensitive ASX Announcement
Full Release
Key Points
- Super Retail Group reported 2% like-for-like sales growth and 4% total sales growth in FY25.
- Supercheap Auto's growth was primarily in the auto maintenance category.
- Sales in New Zealand have slowed, increasing competitive pressures.
- Rebel and BCF reported growth despite challenges from previous periods.
- The company plans to open 25 new stores in FY25.
- Investment in customer loyalty programs may affect gross margins.
- The consumer outlook is uncertain due to cost-of-living pressures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fitzroy River Corporation Ltd (FZR) ORDINARY FULLY PAID |
Energy |
$16 |
Quarterly Activities & Cashflow Report
|
24 Oct 2024 8:26AM |
$0.125 |
$0.150 |
risen by
20%
|
|
FZR - Price-sensitive ASX Announcement
Full Release
Key Points
- Royalty income of $216,788 received during the Quarter.
- Total royalty revenue for the year reached $906,795.
- No royalty receipts from Buru Energy due to suspended operations.
- Investment in Bowden's Silver Project includes a A$30.2 million convertible debenture funding package.
- Plans to commercialize the Rafael Gas Discovery are underway.
- The Company maintains a diversified portfolio with ongoing monitoring of investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$28 |
September 2024 Quarterly Activities and Cashflow Report
|
24 Oct 2024 8:25AM |
$0.040 |
$0.063 |
risen by
57.50%
|
|
PHO - Price-sensitive ASX Announcement
Full Release
Key Points
- PhosCo is advancing its Northern Basin Phosphate Project in Tunisia.
- Application for Gassaat Exploration Permit lodged in September 2024.
- Memorandum of Understanding signed for community participation in Gassaat project.
- 10% project participation proposed for impacted communities.
- Funding commitments secured for exploration activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$8,429 |
FDA accepts NDA and grants priority review for Pixclara
|
24 Oct 2024 8:25AM |
$21.110 |
$24.920 |
risen by
18.05%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA accepted NDA for TLX101-CDx (Pixclara) for brain cancer imaging.
- Priority review granted, with a PDUFA goal date of April 26, 2025.
- Pixclara targets glioma in both adult and pediatric patients.
- Designated as orphan drug and granted fast track designation by the FDA.
- Current MRI techniques have significant limitations in glioma diagnosis.
- Pixclara aims to enhance diagnostic clarity and treatment decision-making.
- Potential companion diagnostic for TLX101, an investigational glioblastoma therapy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$8,321 |
Ramsay Australia Investor Presentation
|
24 Oct 2024 8:24AM |
$41.810 |
$36.050 |
fallen by
13.78%
|
|
| NAOS Small Cap Opportunities Company Limited (NSC) ORDINARY FULLY PAID |
Financials |
$39 |
Change of Director's Interest Notice - S Evans
|
24 Oct 2024 8:24AM |
$0.520 |
$0.290 |
fallen by
44.23%
|
|
| Aeeris Ltd (AER) ORDINARY FULLY PAID |
Communication Services |
$5 |
Aeeris Awarded ISO 27001 Certification
|
24 Oct 2024 8:24AM |
$0.076 |
$0.068 |
fallen by
10.53%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
